Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progressive multifocal leukoencephalopathy].

J C Wasmuth1, A Wasmuth-Pietzuch, U Spengler

  • 1Universitätsklinik Bonn. j-c.wasmuth@uni-bonn.de

Medizinische Klinik (Munich, Germany : 1983)
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?

Infection·2026
Same author

Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.

The Journal of antimicrobial chemotherapy·2026
Same author

The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage.

HIV medicine·2023
Same author

Rabies post-exposure prophylaxis in Germany - What are the challenges?

Epidemiology and infection·2021
Same author

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Journal of molecular medicine (Berlin, Germany)·2020
Same author

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?

International journal of hygiene and environmental health·2020

Progressive multifocal leukoencephalopathy (PML) is a fatal demyelinating disease caused by JC-virus reactivation in immunocompromised individuals, particularly those with HIV. Diagnosis involves neurological symptoms, MRI, and JC-virus detection, with emerging therapies like HAART showing promise.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Context:

  • Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system.
  • It is caused by the reactivation of the John Cunningham virus (JC-virus).
  • PML affects approximately 5% of patients with HIV infection, often proving fatal.

Purpose:

  • To summarize the pathogenesis, diagnosis, and current treatment landscape of Progressive Multifocal Leukoencephalopathy (PML).
  • To highlight the role of JC-virus reactivation in immunosuppressive states.

Summary:

  • JC-virus, a persistent infection, is implicated in PML pathogenesis, with potential latency sites including kidneys, bone marrow, lymphocytes, and the brain.
  • Reactivation is triggered by a loss of T-helper cells, common in HIV infection and other immunosuppressive conditions.

Related Experiment Videos

  • Diagnosis relies on clinical presentation, MRI findings, and detection of JC-virus in cerebrospinal fluid or brain tissue.
  • Currently, no definitive therapy exists, but highly active antiretroviral therapy (HAART) and cidofovir show potential.

    • Impact:

    • Improved understanding of PML pathogenesis and JC-virus latency.
    • Enhanced diagnostic approaches for PML.
    • Identification of promising therapeutic strategies, including HAART and cidofovir, for future clinical application.